Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Revenue projections:

Revenue projections for CAPLIPOINT
Revenue projections for CAPLIPOINT

CAPLIPOINT is projected to experience a revenue decline compared to last year, a development that often leads to investor caution. The drop could negatively impact the company's bottom line, as lower revenues typically signal reduced profitability, prompting more conservative investment strategies.

Financial Ratios:

currentRatio 6.965000
forwardPE 21.438562
debtToEquity 0.174000
earningsGrowth 0.175000
revenueGrowth 0.104000
grossMargins 0.602140
operatingMargins 0.300570
trailingEps 70.150000
forwardEps 0.000000

CAPLIPOINT's current ratio being 6.965 suggests the company will have no issues paying off its short-term debt. With sufficient cash reserves and current assets, CAPLIPOINT can easily cover its immediate liabilities, reflecting solid financial health.
CAPLIPOINT's Forward PE ratio is favorable, meaning the stock price aligns well with earnings and isn't overvalued. This allows room for growth, making it an attractive investment for those seeking potential upside while ensuring the stock is not overpriced.
CAPLIPOINT's positive earnings and revenue growth point to business expansion on the horizon. The company is positioned for continued success, with increasing profits and revenue growth highlighting a strong path forward for future growth.
CAPLIPOINT's positive gross and operating margins indicate that the company is performing profitably. These margins reflect efficient cost control and revenue generation, signaling a strong financial foundation for continued success.

Price projections:

Price projections for CAPLIPOINT
Price projections for CAPLIPOINT



Recommendation changes over time:

Recommendations trend for CAPLIPOINT
Recommendations trend for CAPLIPOINT


CAPLIPOINT has garnered a buy bias from analysts recently, suggesting the stock is a good investment opportunity. This may lead to increased investor interest, as CAPLIPOINT is seen as a reliable place to park money for those looking to benefit from potential market gains and company growth.